As of 2025-07-08, the Relative Valuation of Antares Pharma Inc (ATRS) is 7.40 USD. This relative valuation is based on P/E multiples. With the latest stock price at 5.59 USD, the upside of Antares Pharma Inc based on Relative Valuation is 32.4%.
The range of the Relative Valuation is 6.37 - 8.37 USD.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | 19.1x - 25.1x | 22.2x |
| Fair Price | 6.37 - 8.37 | 7.40 |
| Upside | 14.0% - 49.8% | 32.4% |
| Date | P/E |